Multi-drug implications for COVID-19 treatment, opioid safety, and quality measures

This webinar reviews pharmacokinetic and pharmacodynamic concerns with opioids, potential COVID-19 treatment options, and medication use in older adults. Through case examples, it provides insight into how technology, such as MedWise™, can be leveraged to reduce medication-related problems and improve patient outcomes.

MedWise, our medication safety platform, enhances medication reviews by identifying accumulative, simultaneous, multi-drug interactions. MedWise presents actionable opportunities to mitigate risks, demonstrating improved outcomes, reduced costs, and a 5:1 return on investment. Analyze your entire member population to identify and predict which members will clinically benefit from our medication risk mitigation technology. Request your free analysis report!

Access the recorded webinar

    Name (required)


    Email (required)